188 related articles for article (PubMed ID: 1445852)
1. Mechanism of binding of the new antimitotic drug MDL 27048 to the colchicine site of tubulin: equilibrium studies.
Peyrot V; Leynadier D; Sarrazin M; Briand C; Menendez M; Laynez J; Andreu JM
Biochemistry; 1992 Nov; 31(45):11125-32. PubMed ID: 1445852
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence stopped-flow study of the interaction of tubulin with the antimitotic drug MDL 27048.
Silence K; D'Hoore A; Engelborghs Y; Peyrot V; Briand C
Biochemistry; 1992 Nov; 31(45):11133-7. PubMed ID: 1445853
[TBL] [Abstract][Full Text] [Related]
3. Roles of colchicine rings B and C in the binding process to tubulin.
Medrano FJ; Andreu JM; Gorbunoff MJ; Timasheff SN
Biochemistry; 1989 Jun; 28(13):5589-99. PubMed ID: 2775723
[TBL] [Abstract][Full Text] [Related]
4. Interaction of tubulin with bifunctional colchicine analogues: an equilibrium study.
Andreu JM; Gorbunoff MJ; Lee JC; Timasheff SN
Biochemistry; 1984 Apr; 23(8):1742-52. PubMed ID: 6722122
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of tubulin-colchicine recognition: a kinetic study of the binding of the colchicine analogues colchicide and isocolchicine.
Dumortier C; Yan Q; Bane S; Engelborghs Y
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):685-8. PubMed ID: 9581543
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048. A powerful and reversible microtubule inhibitor.
Peyrot V; Leynadier D; Sarrazin M; Briand C; Rodriquez A; Nieto JM; Andreu JM
J Biol Chem; 1989 Dec; 264(35):21296-301. PubMed ID: 2592375
[TBL] [Abstract][Full Text] [Related]
7. A thermodynamic study of the interaction of tubulin with colchicine site ligands.
Menéndez M; Laynez J; Medrano FJ; Andreu JM
J Biol Chem; 1989 Oct; 264(28):16367-71. PubMed ID: 2777794
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of tubulin-colchicine recognition--a kinetic study of the binding of a bicyclic colchicine analogue with a minor modification of the A ring.
Dumortier C; Potenziano JL; Bane S; Engelborghs Y
Eur J Biochem; 1997 Oct; 249(1):265-9. PubMed ID: 9363778
[TBL] [Abstract][Full Text] [Related]
9. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin.
Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL
J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393
[TBL] [Abstract][Full Text] [Related]
10. Different kinetic pathways of the binding of two biphenyl analogues of colchicine to tubulin.
Dumortier C; Gorbunoff MJ; Andreu JM; Engelborghs Y
Biochemistry; 1996 Apr; 35(14):4387-95. PubMed ID: 8605187
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring C' of biphenyl analogues.
Andreu JM; Gorbunoff MJ; Medrano FJ; Rossi M; Timasheff SN
Biochemistry; 1991 Apr; 30(15):3777-86. PubMed ID: 2015233
[TBL] [Abstract][Full Text] [Related]
12. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.
Lin CM; Ho HH; Pettit GR; Hamel E
Biochemistry; 1989 Aug; 28(17):6984-91. PubMed ID: 2819042
[TBL] [Abstract][Full Text] [Related]
13. Interaction of bovine brain tubulin with the 4(1H)-pyrizinone derivative IKP104, an antimitotic drug with a complex set of effects on the conformational stability of the tubulin molecule.
Luduena RF; Roach MC; Prasad V; Chaudhuri AR; Tomita I; Mizuhashi F; Murata K
Biochemistry; 1995 Dec; 34(48):15751-9. PubMed ID: 7495806
[TBL] [Abstract][Full Text] [Related]
14. Cosolvent modulation of the tubulin-colchicine GTPase-activating conformational change: strength of the enzymatic activity.
Perez-Ramirez B; Timasheff SN
Biochemistry; 1994 May; 33(20):6262-7. PubMed ID: 8193141
[TBL] [Abstract][Full Text] [Related]
15. Interaction of tubulin with octyl glucoside and deoxycholate. 2. Protein conformation, binding of colchicine ligands, and microtubule assembly.
Andreu JM; de la Torre J; Carrascosa JL
Biochemistry; 1986 Sep; 25(18):5230-9. PubMed ID: 3768343
[TBL] [Abstract][Full Text] [Related]
16. Podophyllotoxin as a probe for the colchicine binding site of tubulin.
Cortese F; Bhattacharyya B; Wolff J
J Biol Chem; 1977 Feb; 252(4):1134-40. PubMed ID: 14143
[TBL] [Abstract][Full Text] [Related]
17. Effect of colchicine analogues on the dissociation of alpha beta tubulin into subunits: the locus of colchicine binding.
Shearwin KE; Timasheff SN
Biochemistry; 1994 Feb; 33(4):894-901. PubMed ID: 8305437
[TBL] [Abstract][Full Text] [Related]
18. IKP104-induced decay of tubulin: role of the A-ring binding site of colchicine.
Chaudhuri AR; Tomita I; Mizuhashi F; Murata K; Potenziano JL; Ludueña RF
Biochemistry; 1998 Dec; 37(49):17157-62. PubMed ID: 9860828
[TBL] [Abstract][Full Text] [Related]
19. Conformational states of tubulin liganded to colchicine, tropolone methyl ether, and podophyllotoxin.
Andreu JM; Timasheff SN
Biochemistry; 1982 Dec; 21(25):6465-76. PubMed ID: 7150568
[TBL] [Abstract][Full Text] [Related]
20. Methylenedioxy-benzopyran analogs of podophyllotoxin, a new synthetic class of antimitotic agents that inhibit tubulin polymerization.
Batra JK; Kang GJ; Jurd L; Hamel E
Biochem Pharmacol; 1988 Jul; 37(13):2595-602. PubMed ID: 3390218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]